Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 15/20 | 0.49 |
| ▸ | DDB1 | Q16531 | 4/20 | 0.37 |
| ▸ | IKZF3 | Q9UKT9 | 2/20 | 0.36 |
| ▸ | TNF | P01375 | 2/20 | 0.36 |
| ▸ | BRD4 | O60885 | 1/20 | 0.36 |
| ▸ | IL1B | P01584 | 1/20 | 0.36 |
| ▸ | IKZF1 | Q13422 | 1/20 | 0.36 |
| ▸ | IKZF2 | Q9UKS7 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30351833 | 0.92 | CRBN (0.49) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352199 | 0.87 | CRBN (0.55) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352051 | 0.86 | CRBN (0.49) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352133 | 0.86 | CRBN (0.46) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352214 | 0.85 | CRBN (0.46) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352251 | 0.83 | CRBN (0.49) | CRBNDDB1 | |
| SCHEMBL26447586 | 0.83 | IKZF2 (0.53) | CRBNDDB1IKZF3TNFBRD4 | |
| SCHEMBL30352168 | 0.82 | CRBN (0.47) | CRBNDDB1CHRNB2CHRNA4 | |
| SCHEMBL30352050 | 0.81 | CRBN (0.51) | CRBNDDB1IKZF3TNFALDH1A1 | |
| SCHEMBL30351897 | 0.80 | CRBN (0.50) | CRBNDDB1IKZF3TNFALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023066350-A1 | CRBN E3 LIGASE LIGAND COMPOUND, PROTEIN DEGRADING AGENT DEVELOPED ON THE BASIS OF LIGAND COMPOUND, AND THEIR APPLICATIONS | 标新生物医药科技(上海)有限公司 | 2023-04-27 | — | — | WO | claimed |